ArticleESMO open2017

Erlotinib intercalating pemetrexed/cisplatin versus erlotinib alone in Chinese patients with brain metastases from lung adenocarcinoma: a prospective, non-randomised, concurrent controlled trial (NCT01578668).

Haihong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.